Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus
Open accessThe DOI matches its Crossref record; 43 of the 45 references it cites were found in a registry or an index.
Abstract
The restriction of viral receptors and coreceptors to the basolateral surface of airway epithelial cells has been blamed for the inefficient transfer of viral vectors to the apical surface of this tissue. We now report, however, that differentiated human airway epithelia internalize rAAV type-2 virus efficiently from their apical surfaces, despite the absence of known adeno-associated virus-2 (AAV-2) receptors or coreceptors at these sites. The dramatically lower transduction efficiency of rAAV infection from the apical surface of airway cells appears to result instead from differences in endosomal processing and nuclear trafficking of apically or basolaterally internalized virions. AAV capsid proteins are ubiquitinated after endocytosis, and gene transfer can be significantly enhanced by proteasome or ubiquitin ligase inhibitors. Tripeptide proteasome inhibitors increased persistent rAAV gene delivery from the apical surface >200-fold, to a level nearly equivalent to that achieved with basolateral infection. In vivo application of proteasome inhibitor in mouse lung augmented rAAV gene transfer from undetectable levels to a mean of 10.4 +/- 1.6% of the epithelial cells in large bronchioles. Proteasome inhibitors also increased rAAV-2-mediated gene transfer to the liver tenfold, but they did not affect transduction of skeletal or cardiac muscle. These findings suggest that tissue-specific ubiquitination of viral capsid proteins interferes with rAAV-2 transduction and provides new approaches to circumvent this barrier for gene therapy of diseases such as cystic fibrosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In vitro and preclinical animal studies have shown administration of bortezomib prevents degradation of internalized AAVs, reduces capsid presentation, and increases transduction efficiency by enhancing nuclear translocation of AAV [165, 224, 225].”
From Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer (2023) · cites this paper as [224]
In the citing paper
“After entry into cells, AAV cells can be ubiquitinated for degradation in proteasomes (91), generating increased amount of antigens for immune activation.”
From A versatile toolkit for overcoming AAV immunity (2022) · cites this paper as [91]
In the citing paper
“AAV capsids undergo proteosome-mediated degradation in the cytoplasm, which may expose the packaged genomes to cytoplasmic DNA sensors.”
From Innate immune sensing of adeno-associated virus vectors (2024) · cites this paper as [43]
Citations
Cites
Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., & Goldberg, A. L. (1994) · Cell · doi:10.1016/s0092-8674(94)90462-6 · Cited by 2,524 · cited 1×
“Several specific, cellpermeable, peptide aldehyde inhibitors of proteasome pathways have recently been discovered (30, 31).”
BackgroundFenteany, G., Standaert, R. F., Lane, W. S., Choi, S., Corey, E. J., & Schreiber, S. L. (1995) · Science · doi:10.1126/science.7732382 · Cited by 1,583 · cited 1×
“Several specific, cellpermeable, peptide aldehyde inhibitors of proteasome pathways have recently been discovered (30, 31).”
BackgroundSummerford, C., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1438-1445.1998 · Cited by 1,406 · cited 1×
“Recently, the heparin sulfate proteoglycan receptor (3), and FGFR-1 (4) and αVβ5 integrin (5) coreceptors for AAV-2, have been localized to the basolateral membrane of polarized airway epithelial cells (6, 7).”
BackgroundMultiple proteolytic systems, including the proteasome, contribute to CFTR processing
Jensen, T. J., Loo, M. A., Pind, S., Williams, D. B., Goldberg, A. L., & Riordan, J. R. (1995) · Cell · doi:10.1016/0092-8674(95)90241-4 · Cited by 897 · cited 18×
“A similar result was achieved when another ubiquitinproteasome pathway inhibitor, Z-LLL (33), was tested (data not shown).”
BackgroundInfluentialαVβ5 integrin: a co-receptor for adeno-associated virus type 2 infection
Summerford, C., Bartlett, J. S., & Samulski, R. J. (1999) · Nature Medicine · doi:10.1038/4768 · Cited by 711
Fisher, K. J., Gao, G. P., Weitzman, M. D., DeMatteo, R., Burda, J. F., & Wilson, J. M. (1996) · Journal of Virology · doi:10.1128/jvi.70.1.520-532.1996 · Cited by 547 · cited 2×
“Alternative approaches have attempted to increase transgene expression by enhancing the molecular conversion of nonfunctional viral genomes to expressible forms, as in the case of rAAV (12, 13), or by increasing transcription and translation efficiency by altering the transgene expression cassettes (14).”
BackgroundDuan, D., Sharma, P., Yang, J., Yue, Y., Dudus, L., Zhang, Y., Fisher, K. J., & Engelhardt, J. F. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8568-8577.1998 · Cited by 522 · cited 2×
“It has been previously shown that AAV transduction in certain tissues such as muscle and retina is very efficient (16, 38), whereas other tissues including lung and liver are less favorably transduced (6, 39).”
BackgroundMethodSelf-citationThe Ubiquitin-Proteasome Pathway and Pathogenesis of Human Diseases
Schwartz, P., & Ciechanover, M. (1999) · Annual Review of Medicine · doi:10.1146/annurev.med.50.1.57 · Cited by 466 · cited 2×
“Regulated intracellular proteolysis through proteasomes plays a critical role in many physiological and pathological conditions (35).”
BackgroundSamulski, R. J., Chang, L. S., & Shenk, T. (1987) · Journal of Virology · doi:10.1128/jvi.61.10.3096-3101.1987 · Cited by 449 · cited 1×
“The entire β-galactosidase expression cassette, including the RSV promoter, β-galactosidase reporter gene, and SV40 polyA signal, was excised by Sal I digestion and subsequently cloned into the pSub201 backbone by blunt-end ligation (18).”
MethodHuman fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2
Qing, K., Mah, C., Hansen, J., Zhou, S., Dwarki, V., & Srivastava, A. (1999) · Nature Medicine · doi:10.1038/4758 · Cited by 443
Research works printed but not linked: 3
- Zabner, 1996, Gene Ther, 3, 458
- Hughes, 1993, Lab Invest, 69, 173
- Bennett, 1997, Invest Ophthalmol Vis Sci, 38, 2857
Cited by
Items 301–389 of 389
Alton, E. W. F. W., Geddes, D. M., & Davies, J. C. (2003) · CRC Press eBooks · doi:10.1201/9780203912331.ch14 · Cited by 7
Synthesis and inhibition study on tripeptide inhibitor modified poly( l -lysine) dendrimers
Zhang, X., Luo, K., Wang, G., Nie, Y., He, B., Wu, Y., & Gu, Z. (2010) · Journal of Biomaterials Applications · doi:10.1177/0885328210386821 · Cited by 6
“The proteasome inhibitors first used in gene transfection were reported by Duan et al.13 These authors found that the transduction level of viral vectors increased 200-fold in the presence of tripeptide proteasome inhibitor Calpain inhibitor I or MG 132.”
MethodTargeted Gene Insertion for Functional CFTR Restoration in Airway Epithelium
Barillà, C., Suzuki, S., Rab, A., Sorscher, E. J., & Davis, B. R. (2022) · Frontiers in Genome Editing · doi:10.3389/fgeed.2022.847645 · Cited by 7
“Treatment of human airway epithelium by transiently disrupting tight junctions or inhibiting proteasomal processing facilitates AAV transduction (Coyne et al., 2000; Duan et al., 2000; Yan et al., 2004; Ellis et al., 2013).”
BackgroundHuang, X., Wang, X., Li, L., Qizhao, W., Xu, W., Wu, W., Xie, X., & Diao, Y. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17858 · Cited by 6
Dickey, D. D., Excoffon, K. J. D. A., Young, K. R., Parekh, K. R., & Zabner, J. (2012) · The Journal of Gene Medicine · doi:10.1002/jgm.2632 · Cited by 7
“Other studies have shown different rate-limiting steps for AAV transduction of airway epithelia, including intracellular trafficking and second-strand synthesis [12,13].”
BackgroundAdeno-Associated Virus and AAV Vectors for Gene Delivery
Carter, B., Burstein, H., & PELUSO, R. W. (2008) · CRC Press eBooks · doi:10.1201/9780849387999.ch6 · Cited by 7
Natonson, A., Dean, J., Ii, M., Iwakura, A., & Plante, J. (2010) · Journal of Genetic Syndromes & Gene Therapy · doi:10.4172/2157-7412.1000102 · Cited by 5
“In contrast, EGTA mildly increased rAAV transduction in polarized airway epithelial cells [40].”
Jin, L., Fan, L., Wang, H., LI, Y., Wei, F., & Du, L. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1560 · Cited by 5
“less-permissive cell types with different AAV trafficking defects (27-30) are required to elucidate the exact mechanism of UTMD enhancement in AAV cellular uptake.”
BackgroundRajapaksha, I. G., Angus, P., & Herath, C. B. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.80317 · Cited by 7
“Furthermore, LLnL appears to increase AAV2 capsid ubiquitination that results in augmented gene transfer in different cell types [33], suggesting a mechanism by which these inhibitors increase transduction may be related to ubiquitination.”
BackgroundmGem: AAV, from almost a virus to an awesome vector—or is it?
Srivastava, A. (2026) · mBio · doi:10.1128/mbio.02957-25 · Cited by 5
“…(67), and threonine (68) residues, which serves as a signal for ubiquitination at lysine (69) residues, followed by proteasome-mediated degradation (70, 71), which negatively impacts not only on the transduction efficiency, but the broken down peptides also trigger a cytotoxic T-cell response (72).”
Shiraishi, Y., Adachi, T. K., Cacicedo, J. M., & Ido, Y. (2022) · The FASEB Journal · doi:10.1096/fj.202200840rr · Cited by 4
The significance of triple-capsid-mutant AAV8 for treatment of Sanfilippo Syndrome Type B
Ashby, F. J., & Heldermon, C. D. (2022) · Archives of Stem Cell and Therapy · doi:10.46439/stemcell.3.013 · Cited by 4
“This is particularly apparent by the results published by Gilkes et al. 2016 [49], which suggest wtAAV8 is superior to the two other capsid serotypes currently under clinical trial (AAV5 & AAV9), at least in MPS IIIB mice.”
BackgroundResultSmurf2 alters BPV1 trafficking and decreases infection
Dabydeen, S. A., & Meneses, P. I. (2011) · Archives of Virology · doi:10.1007/s00705-011-0924-0 · Cited by 4
“Regulation of transduction efficiency by ubiquitylation of viral capsid proteins has been demonstrated for the non-enveloped adeno-associated virus (AAV) [10, 34].”
BackgroundWu, H., Chaudhary, A., & Mahato, R. I. (2019) · Springer eBooks · doi:10.1007/978-3-030-00710-2_16 · Cited by 5
Sorscher, E. J., Harris, J. J., Alexander, M., Rottgers, A., Hardy, K. J., Ponnazhagan, S., Collawn, J. F., McClintock, J. B., Amsler, C. D., Webster, A., et al. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302676 · Cited by 4
Liu, X., Luo, M., Zhang, L. N., Yan, Z., Žák, R., Ding, W. Y., Mansfield, S. G., Mitchell, L. G., & Engelhardt, J. F. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.ft-107 · Cited by 4
Self-citationNucleic Acid Cellular Delivery
Xiao, W. S., Zhang, C., Yadava, P., & Hughes, J. A. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-745-1_6 · Cited by 3
Preclinical Study Design for rAAV
Flotte, T. R., Conlon, T. J., & Mueller, C. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-370-7_14 · Cited by 3
A Method for Helper Virus-Free Production of Adeno-Associated Virus Vectors
Collaco, R. F., & Trempe, J. P. (2003) · Humana Press eBooks · doi:10.1385/1-59259-304-6:237 · Cited by 3
Wu, H., & Mahato, R. I. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6486-0_24 · Cited by 3
Mechanism of recombinant adeno-associated virus transduction
Yan, Z., Duan, D., & Engelhardt, J. F. (2005) · CRC Press eBooks · doi:10.1201/b13393-46 · Cited by 3
Self-citationVirus-based vectors for gene expression in mammalian cells: Adeno-associated virus
Xiao, X. (2003) · New comprehensive biochemistry · doi:10.1016/s0167-7306(03)38006-8 · Cited by 3
Ahmadiankia, N., Neshati, V., Neshati, Z., Swildens, J., & de Vries, A. A. F. (2013) · PubMed Central · Cited by 2
The Cold Case Files of rAAV Capsid Influence on Transduction: New Leads
Powell, S. (2025) · Viruses · doi:10.3390/v17111476 · Cited by 2
Strategies for Evading Cellular Immunity Against Recombinant AAV Vectors in Gene Therapy
Wang, Z., Wu, X., Fu, D.-Y., Li, X., Liu, D., Liu, S., Zhao, Q., & Wang, H. (2026) · Current Medical Science · doi:10.1007/s11596-026-00178-9 · Cited by 2
Jäschke, N. M., & Büning, H. (2022) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.04.002 · Cited by 2
Bleomycin promotes rAAV2 transduction via DNA-PKcs/Artemis-mediated DNA break repair pathways
Huang, X., Wang, X., Sun, Y., Li, L., Li, A., Xu, W., Xie, X., & Diao, Y. (2023) · Virology · doi:10.1016/j.virol.2023.109959 · Cited by 2
Longitudinal assessment of DREADD expression and efficacy in the monkey brain
Nagai, Y., Hori, Y., Inoue, K.-I., Hirabayashi, T., Mimura, K., Oyama, K., Miyakawa, N., Hori, Y., Iwaoki, H., Kumata, K., et al. (2025) · eLife · doi:10.7554/elife.105815.3 · Cited by 2
Park, S. Y., Feng, Z., Choi, S. H., Zhang, X., Tang, Y., Gasser, G. N., Richart, D., Yuan, F., Qiu, J., Engelhardt, J. F., et al. (2025) · Human Gene Therapy · doi:10.1089/hum.2024.260 · Cited by 3
“50,51 Doxorubicin (Dox) was utilized to enhance the apical transduction of rAAV6 and rAAV2/HBoV1 in ALI cultures derived from CuFi-8 cells and their derivative reporter cells.”
Self-citationCell adhesion: a partner for many
Gahmberg, C. G. (2004) · Blood · doi:10.1182/blood-2003-12-4113 · Cited by 2
Adeno-associated Virus and AAV Vectors for Gene Delivery
Carter, B., Burstein, H., & PELUSO, R. W. (2003) · CRC Press eBooks · doi:10.1201/9780824758608.ch5 · Cited by 3
Genetic Modification of Somatic Gut Mucosa: An Adeno‐associated Virus Approach
Tang, S., & Sibley, E. (2006) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000232016.33284.82 · Cited by 2
Adeno-associated virus infection of murine fibroblasts with help provided by mouse adenovirus
Bhrigu, V., & Trempe, J. P. (2009) · Virology · doi:10.1016/j.virol.2009.04.020 · Cited by 4
“…on the cell surface thereby allowing binding and internalization of virus, trafficking from the cell membrane to the nucleus (Bartlett et al., 2000; Duan et al., 2000) and conversion of singlestranded AAV DNA to a transcriptionally active double-stranded conformation (Ferrari et al., 1996; Fisher…”
BackgroundCardiac Cell and Gene Transfer
Metzger, J. M. (2002) · Humana Press eBooks · doi:10.1385/159259350x · Cited by 2
Longitudinal assessment of DREADD expression and efficacy in the monkey brainPreprint
Nagai, Y., Hori, Y., Inoue, K.-I., Hirabayashi, T., Mimura, K., Oyama, K., Miyakawa, N., Hori, Y., Iwaoki, H., Kumata, K., et al. (2025) · eLife · doi:10.7554/elife.105815 · Cited by 5
Virus Vectors for use in the Central Nervous System
Lehtonen, E., & Tenenbaum, L. (2003) · International review of neurobiology · doi:10.1016/s0074-7742(03)01002-x · Cited by 1
Park, S. Y., Feng, Z., Zhang, X., Tang, Y., Richart, D., Vorhies, K., Qiu, J., Engelhardt, J. F., & Yan, Z. (2025) · Viruses · doi:10.3390/v17060821 · Cited by 1
“Because rAAV apical transduction encounters post-entry barriers that limit nuclear transport [44,45], doxorubicin (Dox) was used to enhance rAAV2.”
Self-citationThe role of post-translational modifications in parvovirus life cycle
Liu, P., & Yang, L.-Q. (2025) · Frontiers in Veterinary Science · doi:10.3389/fvets.2025.1634345 · Cited by 2
Gene Therapy for Lung Diseases
Alton, E. W. F. W., Davies, J. C., & Geddes, D. M. (2006) · Humana Press eBooks · doi:10.1007/978-1-59259-963-9_28 · Cited by 1
Swinging for the fences: persistent and efficient liver-directed gene therapy for hemophilia A
Flotte, T. R. (2004) · Blood · doi:10.1182/blood-2003-12-4115 · Cited by 1
Yan, Z., Lei-Butters, D. C. M., Zhang, Y., Žák, R., & Engelhardt, J. F. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.ft-274 · Cited by 1
Self-citationGene Therapy for Parkinson’s Disease: Towards Non Invasive Approaches
Rodríguez, M., Jose, M., & Castro, R. (2011) · InTech eBooks · doi:10.5772/20631 · Cited by 1
“In general, tropism is associated with the abundance of a specific receptor /coreceptor, although there are exceptions (Duan et al., 2000).”
BackgroundImmune System Obstacles to In vivo Gene Transfer with Adeno-Associated Virus Vectors
Büning, H., & Mingozzi, F. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800563-7.00004-x · Cited by 1
Amelioration of airway and GI disease in G551D-CF ferrets by AAV1 and AAV6
Ciobanu, C., Yanda, M. K., Zeidan, A., Izzi, J. M., Guggino, W. B., & Cebotaru, L. (2024) · Gene Therapy · doi:10.1038/s41434-024-00469-7 · Cited by 1
“Thus, the increase in endogenous CFTR in the monkeys most likely resulted from the increase”
Identification of Novel Adeno-Associated Virus Serotypes for Use as Vectors
Vandenberghe, L. H., Wilson, J. M., & Gao, G. (2006) · Elsevier eBooks · doi:10.1016/b978-012397632-1/50003-4 · Cited by 2
The State of the Art and Future of Gene Medicines
Jacobs, F., Gordts, S. C., & Geest, B. D. (2013) · Wiley eBooks · doi:10.1002/9780470571224.pse515 · Cited by 1
Xiao, X. (2001) · Wiley eBooks · doi:10.1038/npg.els.0000408 · Cited by 1
Adeno Associated Viral Vectors for the Nervous System
Kaspar, B. K., & Gage, F. H. (2006) · CRC Press eBooks · doi:10.3109/9781420016390-4 · Cited by 1
Gene Delivery Technology: Adeno- Associated Virus
Carter, B. (2003) · Drugs and the pharmaceutical sciences · doi:10.1201/9780203912331.ch8 · Cited by 1
Targeted Gene Modification of the Nervous System
Cortés, M. L., & Breakefield, X. O. (2006) · CRC Press eBooks · doi:10.3109/9781420016390-7 · Cited by 1
Longitudinal assessment of DREADD expression and efficacy in the monkey brainPreprint
Nagai, Y., Hori, Y., Inoue, K.-I., Hirabayashi, T., Mimura, K., Oyama, K., Miyakawa, N., Hori, Y., Iwaoki, H., Kumata, K., et al. (2025) · eLife · doi:10.7554/elife.105815.1 · Cited by 1
Molecular biology: from the bench to clinical application
Morales, M. M. (2007) · Springer eBooks · doi:10.1007/88-470-0407-1_2
Strategies for improving adeno-associated viral infection of airway epithelial cells
Dickey, D. D. (2012) · doi:10.17077/etd.m1aiqczb
“AAV2, while others have found that intracellular trafficking and second strand synthesis are rate limiting steps (90, 171).”
BackgroundInfluentialSteines, B. R., Zabner, J., Meier, J. L., Adams, C. M., McCray, P. B., & Yeaman, C. A. (2015) · doi:10.17077/etd.tdj11wfe
Visualization of the intracellular trafficking of incoming Adeno-associated virus type 2
Lux, K. (2006) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.8690
Generation of enhanced gene delivery vectors by directed evolution of adeno-associated virus
Endell, J. (2006) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.5436
Yang, Z., Zhang, Y., Fu, Z., Wang, H., & Ma, H. (2013) · ICME International Conference on Complex Medical Engineering (CME) · doi:10.1109/iccme.2013.6548232
Driskell, R. R., & Engelhardt, J. F. (2003)
Self-citationThe Impact of Peptide Insertions on Adeno-Associated Viral Vector Fate
Uhrig, S. (2010) · Kölner Universitäts PublikationsServer (Universität zu Köln)
Serotypen des Adeno-assoziierten Virus und ihre potentielle Anwendung in der Gentherapie von Tumoren
München, L.-M.-U., & Cramer, P. (2007)
Design of Gene Therapy Clinical Trials in CF Patients
Curlee, K. V., & Sorscher, E. J. (2003) · Humana Press eBooks · doi:10.1385/1-59259-187-6:575
Mitchell, A. M. (2013) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/f5kg-n202
Chemical Modulation of AAV Trafficking
Berry, G. E. (2016) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/dpe3-gy73
Intracellular fate of AAV particles in human Dendritic Cell and impact on Gene Transfer
Rossi, A. (2016) · theses.fr (ABES) · doi:10.70675/4518d4eazdbd8z4f46z96e2zf87942913c70
“However, the proteasome inhibitor MG132 was also shown to be able to increase the transduction efficiency by another obscure mechanism which improves AAV nuclear translocation [83], [108].”
BackgroundXiao, P. (2013) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/rn9x-xq74
Nicolson, S. C. (2014) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/gbv4-z740
Comparative Efficacy of Intratracheal Adeno-Associated Virus Administration to Newborn Rats
Fleurence, E., Rivière, C., Lacaze‐Masmonteil, T., Franco‐Montoya, M., Waszak, P., Bourbon, J. R., Danos, O., Douar, A. M., & Delacourt, C. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.ft-136
High, K. A. (2023) · PubMed Central · Cited by 2
Longitudinal assessment of DREADD expression and efficacy in the monkey brainPreprint
Nagai, Y., Hori, Y., Inoue, K., Hirabayashi, T., Mimura, K., Oyama, K., Miyakawa, N., Hori, Y., Iwaoki, H., Kumata, K., et al. (2025) · eLife · doi:10.7554/elife.105815.2
Exploring potential analgesic targets and tools for chronic pain treatment
Haroun, R. (2023) · UCL Discovery (University College London)
Gene Therapy in Nonneoplastic Lung Disease
Allen, T. C., & Cagle, P. T. (2008) · Molecular pathology library · doi:10.1007/978-0-387-72430-0_48
Adenovirus biology : receptors and intracellular trafficking
Henaff, D. (2010) · theses.fr (ABES) · doi:10.70675/ca607948z0dbez4c04za01bz5f8aa67e4701
Développement d’approches thérapeutiques pour le traitement des dysferlinopathies.
Pryadkina, M. (2014) · theses.fr (ABES) · doi:10.70675/27b540eaz8392z44b7zbfb0zbc47b0821d32
Characterization of rAAV vectors packaging in baculovirusinfected insect cells
Penaud‐Budloo, M. (2018) · theses.fr (ABES) · doi:10.70675/c5cff6daz8fe4z430cz80e6z97a11cc59c8e
Chassagne, J. (2019) · theses.fr (ABES) · doi:10.70675/74df0299z4167z4397zb93fz28bc889326f4
Etude des réponses T CD8+ après transfert de gène par rAAV ciblant le muscle
Jeanpierre, L. (2024) · theses.fr (ABES) · doi:10.70675/430aceacz50d2z426bz907dz876c55d1e935
Optimized AAV capsids robustly transduce airway epithelial cellsPreprint
Cooney, A. L., Chen, Y. H., Lewandowski, B. C., Lamer, S., Boysen, G., Kulhánková, K., Vu, A., Newase, P., Sinn, P. L., Davidson, B. L., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.10.723853
“Proteosome inhibitors have been shown to increase AAV-mediated transduction through multiple mechanisms, including the inhibition of capsid ubiquitination and the facilitation of microtubule transport of capsids to the nuclear envelope 21,34,35 .”
Bovine AAV: A promising vector for pulmonary gene therapy
Ivan, D. C., Dubost, V., Israël, L., Weinmann, J., Ungan, D., Carbonetti, N., Stuber, N., Jivkov, M., Erard, E., Biglieri, E., et al. (2026) · Molecular Therapy Advances · doi:10.1016/j.omta.2026.201859
Molecular biology and lung disease What is the impact?
de Andrade, A. C., & Morales, M. M. (2007) · Springer eBooks · doi:10.1007/88-470-0351-2_24
Estrategias de transferencia génica en cerebro mediadas por vectores virales adenoasociados
Armas, J. M. B., Marrero, I. G., Perdomo, A. L. C., Calero, E. M. C., Fumero, A. A., Hernández, J. R. C., & Fuentes, R. (2009) · Majorensis: Revista Electrónica de Ciencia y Tecnología
Proteasome inhibitors as complementary or alternative antiviral therapeutics
Prösch, S., & Kaspari, M. (2006) · Springer eBooks · doi:10.1007/978-0-387-31047-3_17
“Normally, in less efficiently transduced cells incoming virus is effectively degraded by the proteasome (Douar et al., 2001; Hansen et al., 2000; Duan et al., 2000).”
BackgroundInfluentialTraister, R. S. (2006) · D-Scholarship@Pitt (University of Pittsburgh)
Metadata
- Authors
- Duan, D., Yue, Y., Yan, Z., Yang, J., & Engelhardt, J. F.
- Affiliations
- University of Iowa (US)
- Corresponding author
- Engelhardt, John F.
- Venue
- Journal of Clinical Investigation
- Published
- 2000-06-01
- Volume
- 105
- Issue
- 11
- Pages
- 1573-1587
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC300848
- OpenAlex
- W1970138286
- Cited by
- 391
- References
- 45
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 10 · 2023: 12 · 2022: 8 · 2021: 5 · 2020: 9 · 2019: 17 · 2018: 6 · 2017: 9 · 2016: 4 · 2015: 11 · 2014: 10 · 2013: 18 · 2012: 18
- FWCI
- 13.93
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (DK54759)
- National Heart, Lung, and Blood Institute (R01HL058340)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK54759, P30DK054759)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Keywords
- adeno-associated virus type 2, airway epithelium, endosomal processing, proteasome inhibitors, ubiquitin ligase inhibitors, nuclear trafficking, pulmonary gene therapy, cystic fibrosis
- MeSH terms
- Dependovirus, Animals, Bronchi, Capsid, Cells, Cultured, Cysteine Endopeptidases, Egtazic Acid, Epithelial Cells, Humans, Lung, Mice, Inbred BALB C, Multienzyme Complexes, Endosomes, Ubiquitins, Genetic Therapy, Cell Polarity, Gene Transfer Techniques, Proteasome Endopeptidase Complex, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.